-
Subject Areas on Research
-
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
-
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
-
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.
-
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
-
Activity of temozolomide in the treatment of central nervous system tumor xenografts.
-
Acute leukemia following treatment of malignant glioma.
-
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
-
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
-
CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma.
-
Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial.
-
Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas.
-
Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients.
-
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.
-
Hodgkin's disease presenting as myelofibrosis.
-
Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation.
-
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.
-
Intracerebral growth of a human glioma tumor line in athymic mice and treatment with procarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, aziridinylbenzoquinone, and cis-platinum.
-
Long-term follow-up of survival in Hodgkin's lymphoma.
-
O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts.
-
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.
-
PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.
-
Positive therapeutic interaction between thiopurines and alkylating drugs in human glioma xenografts.
-
Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort.
-
Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
-
Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
-
Retroperitoneal fibrosis following treatment for Hodgkin's disease.
-
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
-
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
-
Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors.
-
Treatment of five subcutaneous human glioma tumor lines in athymic mice with carmustine, procarbazine, and mithramycin.